Literature DB >> 8055437

Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada.

D B Kopans1, E Halpern, C A Hulka.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 8055437     DOI: 10.1002/1097-0142(19940815)74:4<1196::aid-cncr2820740403>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

Review 1.  Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.

Authors:  J Ringash
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

2.  Arguments against mammography screening continue to be based on faulty science.

Authors:  Daniel B Kopans
Journal:  Oncologist       Date:  2014-02

Review 3.  The wisdom trial is based on faulty reasoning and has major design and execution problems.

Authors:  Daniel B Kopans
Journal:  Breast Cancer Res Treat       Date:  2020-11-25       Impact factor: 4.872

4.  Impact of mammography detection on the course of breast cancer in women aged 40-49 years.

Authors:  Judith A Malmgren; Jay Parikh; Mary K Atwood; Henry G Kaplan
Journal:  Radiology       Date:  2012-03       Impact factor: 11.105

5.  The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses.

Authors:  Tara Byrne; Helen G Coleman; Janine A Cooper; W Glenn McCluggage; Amanda McCann; Fiona Furlong
Journal:  Oncotarget       Date:  2017-06-08

6.  Misinformation and Facts about Breast Cancer Screening.

Authors:  Daniel B Kopans
Journal:  Curr Oncol       Date:  2022-08-09       Impact factor: 3.109

Review 7.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

Review 8.  Should women under 50 be screened for breast cancer?

Authors:  S Moss
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.